AbbVie (ABBV) Other Non-Current Assets (2012 - 2026)

AbbVie (ABBV) has reported Other Non-Current Assets for 15 consecutive years, with $10.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 11.05% year-over-year to $10.7 billion in Q2 2026; TTM through Jun 2026 was $10.7 billion, a 11.05% increase from a year earlier, with the FY2025 full-year figure at $10.7 billion, up 17.27% from the prior year.
• Other Non-Current Assets was $10.7 billion for Q2 2026 at AbbVie, up from $10.5 billion in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $10.7 billion in Q2 2026 and troughed at $5.0 billion in Q2 2022.
• A 5-year average of $8.0 billion and a median of $8.8 billion in 2023 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets surged 56.33% in 2024 and increased 1.38% in 2025, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $5.6 billion in 2022, then jumped by 52.81% to $8.5 billion in 2023, then rose by 7.39% to $9.1 billion in 2024, then gained by 17.27% to $10.7 billion in 2025, then rose by 0.05% to $10.7 billion in 2026.
• The last three Other Non-Current Assets figures came in at $10.7 billion (Q2 2026), $10.5 billion (Q1 2026), and $10.7 billion (Q4 2025), per Business Quant data.